The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.

NCT06907329 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Immunosenescence
Metabolism

Interventions

DIETARY_SUPPLEMENT: NMN
DIETARY_SUPPLEMENT: Placebo

Sponsor

Qing Su